Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ORMPthis companyOramed Pharmaceuticals Inc.	$3.94	1.86×	0.59×	59×	0.97×	-70.9%	0.7%	-754.4%	3202.5%	32.1%	-6.0%	-9.4%	0×	-0.6×	0×	6.98×	0.0%	3	3.38	5	S-
CLNNClene Inc.	$4.09	-2.22×	-3.29×	289.36×	-3.38×	-148.3%	78.5%	-11541.5%	-13086.5%	148.8%	-188.6%	-32.1%	-1.23×	-0.75×	-8.61×	0.83×	0.0%	2	-23.05	2	C
CNTBConnect Biopharma Holdings Limited	$0.74	-2.82×	3.74×	2,452.52×	-2.19×	-15.8%	100.0%	-90740.6%	-86687.5%	-132.2%	-135.7%	-32.9%	0.02×	0.69×	0×	3.74×	0.0%	2	-15.61	2	C+
CNTXContext Therapeutics Inc.	$0.19	-3.87×	2.31×	0×	-2.05×	231.0%	0.0%	0.0%	0.0%	-59.7%	-65.5%	-18.9%	0×	1.82×	0×	8.52×	0.0%	2	-5.58	3	B
COYACoya Therapeutics, Inc.	$2.93	-4.57×	2.26×	12.21×	-2.37×	45.7%	99.7%	-255.0%	-267.1%	-49.3%	-46.0%	-11.1%	0×	2.21×	0×	8.5×	0.0%	3	8.76	1	D+
IMAImageneBio Inc	$4.11	-0.72×	0.28×	46.85×	-0.28×	9.5%	-29.1%	-6056.4%	-5668.6%	-34.1%	-33.4%	-127.6%	0.08×	0.56×	0×	12.49×	0.0%	1	0.37	3	B
Peer median	—	-2.82×	2.26×	46.85×	-2.19×	9.5%	78.5%	-6056.4%	-5668.6%	-49.3%	-65.5%	-32.1%	0×	0.69×	0×	8.5×	0.0%	2	-5.58	2	—